ID   DHRS2_HUMAN             Reviewed;         280 AA.
AC   Q13268; D3DS54; Q53GS4; Q7Z789; Q9H2R2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2013, sequence version 4.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Dehydrogenase/reductase SDR family member 2, mitochondrial;
DE            EC=1.1.1.-;
DE   AltName: Full=Dicarbonyl reductase HEP27;
DE   AltName: Full=Protein D;
DE   AltName: Full=Short chain dehydrogenase/reductase family 25C member 1;
DE   Flags: Precursor;
GN   Name=DHRS2; Synonyms=SDR25C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 24-41.
RC   TISSUE=Hepatoma;
RX   PubMed=7556196; DOI=10.1111/j.1432-1033.1995.473zz.x;
RA   Gabrielli F., Donadel G., Bensi G., Heguy A., Melli M.;
RT   "A nuclear protein, synthesized in growth-arrested human
RT   hepatoblastoma cells, is a novel member of the short-chain alcohol
RT   dehydrogenase family.";
RL   Eur. J. Biochem. 232:473-477(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SUBCELLULAR LOCATION.
RX   PubMed=11997086; DOI=10.1016/S0167-4781(01)00323-2;
RA   Pellegrini S., Censini S., Guidotti S., Iacopetti P., Rocchi M.,
RA   Bianchi M., Covacci A., Gabrielli F.;
RT   "A human short-chain dehydrogenase/reductase gene: structure,
RT   chromosomal localization, tissue expression and subcellular
RT   localization of its product.";
RL   Biochim. Biophys. Acta 1574:215-222(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 10-280 (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 80-88; 141-146; 148-162 AND 198-205, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=1847869; DOI=10.1111/j.1432-1033.1991.tb15759.x;
RA   Donadel G., Garzelli C., Frank R., Gabrielli F.;
RT   "Identification of a novel nuclear protein synthesized in growth-
RT   arrested human hepatoblastoma HepG2 cells.";
RL   Eur. J. Biochem. 195:723-729(1991).
RN   [8]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11944995; DOI=10.1006/geno.2002.6743;
RA   Heinz S., Krause S.W., Gabrielli F., Wagner H.M., Andreesen R.,
RA   Rehli M.;
RT   "Genomic organization of the human gene HEP27: alternative promoter
RT   usage in HepG2 cells and monocyte-derived dendritic cells.";
RL   Genomics 79:608-615(2002).
RN   [9]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16685466; DOI=10.1007/s00018-006-6013-y;
RA   Shafqat N., Shafqat J., Eissner G., Marschall H.U., Tryggvason K.,
RA   Eriksson U., Gabrielli F., Lardy H., Jornvall H., Oppermann U.;
RT   "Hep27, a member of the short-chain dehydrogenase/reductase family, is
RT   an NADPH-dependent dicarbonyl reductase expressed in vascular
RT   endothelial tissue.";
RL   Cell. Mol. Life Sci. 63:1205-1213(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH MDM2, IDENTIFICATION OF MITOCHONDRIAL
RP   TRANSIT PEPTIDE CLEAVAGE SITE, AND SUBCELLULAR LOCATION.
RX   PubMed=20547751; DOI=10.1128/MCB.01284-09;
RA   Deisenroth C., Thorner A.R., Enomoto T., Perou C.M., Zhang Y.;
RT   "Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and
RT   stabilizes p53.";
RL   Mol. Cell. Biol. 30:3981-3993(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-272.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Displays NADPH-dependent dicarbonyl reductase activity
CC       in vitro with 3,4-Hexanedione, 2,3-Heptanedione and 1-Phenyl-1,2-
CC       propanedione as substrates. No reductase activity is displayed in
CC       vitro with steroids, retinoids and sugars as substrates.
CC       Attenuates MDM2-mediated p53/TP53 degradation, leading to p53/TP53
CC       stabilization and increased transcription activity, resulting in
CC       the accumulation of MDM2 and CDKN1A/p21.
CC       {ECO:0000269|PubMed:16685466, ECO:0000269|PubMed:20547751}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3 mM for 1-Phenyl-1,2-propanedione
CC         {ECO:0000269|PubMed:16685466};
CC         KM=1.1 mM for 2,3-Heptanedione {ECO:0000269|PubMed:16685466};
CC         KM=0.8 mM for 3,4-Hexanedione {ECO:0000269|PubMed:16685466};
CC         Vmax=0.52 mmol/min/mg enzyme with 1-Phenyl-1,2-propanedione as
CC         substrate {ECO:0000269|PubMed:16685466};
CC         Vmax=0.64 mmol/min/mg enzyme with 2,3-Heptanedione as substrate
CC         {ECO:0000269|PubMed:16685466};
CC         Vmax=0.35 mmol/min/mg enzyme with 3,4-Hexanedione as substrate
CC         {ECO:0000269|PubMed:16685466};
CC   -!- SUBUNIT: Directly interacts with MDM2; this interaction occurs in
CC       the nucleus and does not target DHRS2 to degradation.
CC       {ECO:0000269|PubMed:20547751}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-354324, EBI-743771;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix. Nucleus. Note=A minor
CC       fraction of the protein is translocated from the mitochondria to
CC       the nucleus, after cleavage of the targeting signal.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13268-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13268-2; Sequence=VSP_038179;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in liver
CC       and kidney, followed by heart, spleen, skeletal muscle and
CC       placenta. In hemopoietic cells, expressed in dendritic cells, but
CC       not in monocytes, macrophages, granulocytes, nor in B and T
CC       lymphocytes. {ECO:0000269|PubMed:11944995}.
CC   -!- INDUCTION: Up-regulated by IL4 and CSF2 in monocytes/macrophages.
CC       Down-regulated by bacterial lipopolysaccharides (LPS) and TNF in
CC       monocytice-derived dendritic cells. Up-regulated by MYB.
CC       {ECO:0000269|PubMed:11944995}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U31875; AAA82048.1; -; mRNA.
DR   EMBL; AF244132; AAG33703.1; -; Genomic_DNA.
DR   EMBL; AK222857; BAD96577.1; -; mRNA.
DR   EMBL; AL135999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW66130.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66131.1; -; Genomic_DNA.
DR   EMBL; BC002786; AAH02786.1; -; mRNA.
DR   EMBL; BC007339; AAH07339.2; -; mRNA.
DR   CCDS; CCDS41927.1; -. [Q13268-2]
DR   CCDS; CCDS9604.1; -. [Q13268-1]
DR   PIR; S66665; S66665.
DR   RefSeq; NP_005785.1; NM_005794.3. [Q13268-1]
DR   RefSeq; NP_878912.1; NM_182908.4. [Q13268-2]
DR   RefSeq; XP_005267306.1; XM_005267249.1. [Q13268-1]
DR   RefSeq; XP_006720064.1; XM_006720001.3. [Q13268-1]
DR   UniGene; Hs.272499; -.
DR   ProteinModelPortal; Q13268; -.
DR   SMR; Q13268; -.
DR   BioGrid; 115497; 26.
DR   IntAct; Q13268; 19.
DR   STRING; 9606.ENSP00000344674; -.
DR   iPTMnet; Q13268; -.
DR   PhosphoSitePlus; Q13268; -.
DR   BioMuta; DHRS2; -.
DR   DMDM; 527504085; -.
DR   EPD; Q13268; -.
DR   MaxQB; Q13268; -.
DR   PaxDb; Q13268; -.
DR   PeptideAtlas; Q13268; -.
DR   PRIDE; Q13268; -.
DR   DNASU; 10202; -.
DR   Ensembl; ENST00000250383; ENSP00000250383; ENSG00000100867. [Q13268-1]
DR   Ensembl; ENST00000344777; ENSP00000344674; ENSG00000100867. [Q13268-2]
DR   Ensembl; ENST00000611765; ENSP00000481607; ENSG00000100867. [Q13268-2]
DR   GeneID; 10202; -.
DR   KEGG; hsa:10202; -.
DR   UCSC; uc001wkt.5; human. [Q13268-1]
DR   CTD; 10202; -.
DR   DisGeNET; 10202; -.
DR   GeneCards; DHRS2; -.
DR   HGNC; HGNC:18349; DHRS2.
DR   HPA; HPA053915; -.
DR   HPA; HPA069551; -.
DR   MIM; 615194; gene.
DR   neXtProt; NX_Q13268; -.
DR   OpenTargets; ENSG00000100867; -.
DR   PharmGKB; PA38318; -.
DR   eggNOG; KOG0725; Eukaryota.
DR   eggNOG; COG1028; LUCA.
DR   GeneTree; ENSGT00760000118868; -.
DR   HOVERGEN; HBG105779; -.
DR   InParanoid; Q13268; -.
DR   KO; K11164; -.
DR   OMA; QEGCNIA; -.
DR   OrthoDB; EOG091G0G3R; -.
DR   TreeFam; TF315405; -.
DR   SABIO-RK; Q13268; -.
DR   ChiTaRS; DHRS2; human.
DR   GeneWiki; DHRS2; -.
DR   GenomeRNAi; 10202; -.
DR   PRO; PR:Q13268; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100867; -.
DR   CleanEx; HS_DHRS2; -.
DR   ExpressionAtlas; Q13268; baseline and differential.
DR   Genevisible; Q13268; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0008207; P:C21-steroid hormone metabolic process; NAS:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; IEP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IDA:UniProtKB.
DR   InterPro; IPR027052; DHRS2.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR42760:SF11; PTHR42760:SF11; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Mitochondrion; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     23       Mitochondrion.
FT                                {ECO:0000269|PubMed:7556196}.
FT   CHAIN        24    280       Dehydrogenase/reductase SDR family member
FT                                2, mitochondrial.
FT                                /FTId=PRO_0000054642.
FT   NP_BIND      40     64       NAD or NADP. {ECO:0000250}.
FT   ACT_SITE    185    185       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING     172    172       Substrate. {ECO:0000250}.
FT   MOD_RES      96     96       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES      96     96       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     219    219       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     219    219       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     223    223       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   MOD_RES     237    237       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99LB2}.
FT   VAR_SEQ     226    280       FHGNESLWKNFKEHHQLQRIGESEDCAGIVSFLCSPDASYV
FT                                NGENIAVAGYSTRL -> VRIGFMGMSLSGRTSRNIISCRG
FT                                LGSQRTVQESCPSCALQMPATSTGRTLRWQATPLGSERSGG
FT                                GCVAVVPGPGA (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038179.
FT   VARIANT     272    272       A -> V (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs148991912).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035846.
FT   CONFLICT     14     14       H -> R (in Ref. 3; BAD96577).
FT                                {ECO:0000305}.
FT   CONFLICT     80     80       L -> V (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     85     85       L -> G (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       L -> P (in Ref. 3; BAD96577).
FT                                {ECO:0000305}.
FT   CONFLICT    173    173       I -> V (in Ref. 3; BAD96577).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       N -> S (in Ref. 3; BAD96577).
FT                                {ECO:0000305}.
SQ   SEQUENCE   280 AA;  29927 MW;  FE76ED9CB28AB95C CRC64;
     MLSAVARGYQ GWFHPCARLS VRMSSTGIDR KGVLANRVAV VTGSTSGIGF AIARRLARDG
     AHVVISSRKQ QNVDRAMAKL QGEGLSVAGI VCHVGKAEDR EQLVAKALEH CGGVDFLVCS
     AGVNPLVGST LGTSEQIWDK ILSVNVKSPA LLLSQLLPYM ENRRGAVILV SSIAAYNPVV
     ALGVYNVSKT ALLGLTRTLA LELAPKDIRV NCVVPGIIKT DFSKVFHGNE SLWKNFKEHH
     QLQRIGESED CAGIVSFLCS PDASYVNGEN IAVAGYSTRL
//
